OAG

Tracking treatment adherence in newly diagnosed open-angle glaucoma
Tracking treatment adherence in newly diagnosed open-angle glaucomaAn analysis of U.S. claims data reveals a substantial proportion of patients (17%) remained untreated 4 years after their initial diagnosis of open-angle glaucoma.
MIGS study: Role of two stents for IOPImplantation of two stents (iStent, Glaukos) may be another option for controlling IOP in phakic and pseudophakic patients with open-angle glaucoma who are refractory to one anti-glaucoma medication.
SLT effective part of glaucoma care strategy in developing countriesSelective laser trabeculoplasty provided a majority of Afro-Caribbean patients with a mean IOP reduction of 40% with no need for medical therapy.